#9;(23S,25R)-17-ALPHA,23-EPOXY-29-HYDROXY-3-BETA-[(O-ALPHA-L-RHAMNOPYRANOSYL-(1->2)-O-[BETA-D-GLUCOPYRANOSYL-(1->3)]-BETA-D-GLUCOPYRANOSYL-(1->2)-ALPHA-L-ARABI
Compound with spectra: 1 NMR
![#9;(23S,25R)-17-ALPHA,23-EPOXY-29-HYDROXY-3-BETA-[(O-ALPHA-L-RHAMNOPYRANOSYL-(1->2)-O-[BETA-D-GLUCOPYRANOSYL-(1->3)]-BETA-D-GLUCOPYRANOSYL-(1->2)-ALPHA-L-ARABI](/api/compound/KdLubvtdKBw.png?ph=true&h=300&w=458 "#9;(23S,25R)-17-ALPHA,23-EPOXY-29-HYDROXY-3-BETA-[(O-ALPHA-L-RHAMNOPYRANOSYL-(1->2)-O-[BETA-D-GLUCOPYRANOSYL-(1->3)]-BETA-D-GLUCOPYRANOSYL-(1->2)-ALPHA-L-ARABI")
| SpectraBase Compound ID | KdLubvtdKBw |
|---|---|
| InChI | InChI=1S/C59H94O28/c1-23-16-58(86-48(23)75)17-24(2)59(87-58)15-14-56(6)27-8-9-32-54(4,26(27)10-13-57(56,59)7)12-11-33(55(32,5)22-62)82-50-43(73)41(71)37(67)31(81-50)21-77-52-46(35(65)28(63)20-76-52)84-53-47(85-49-42(72)39(69)34(64)25(3)78-49)45(38(68)30(19-61)80-53)83-51-44(74)40(70)36(66)29(18-60)79-51/h23-25,28-47,49-53,60-74H,8-22H2,1-7H3/t23-,24-,25+,28+,29-,30-,31-,32-,33+,34+,35+,36-,37-,38-,39-,40+,41+,42-,43-,44-,45+,46-,47-,49+,50+,51+,52+,53+,54-,55-,56+,57+,58+,59+/m1/s1 |
| InChIKey | CMHXUBSOBRQNSP-XUJDPLKASA-N |
| Mol Weight | 1251.4 g/mol |
| Molecular Formula | C59H94O28 |
| Exact Mass | 1250.593162 g/mol |
| Enantiomer InChIKey | CMHXUBSOBRQNSP-UKQJDIHISA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | C5D5N |
Dispiro[piperidine-4,2'-[7,14,24,31]tetraoxapentacyclo[30.2.2.23,6.215,18.220,23]dotetraconta[3,5,15,17,20,22,32,34,35,37,39,41]dodecaen e-19',4''-piperidine], 1,1''-diacetyl-5',33'-dibromo-16',22',36',37',40',41'-hexamethyl-
6H,13H-5,13:6,12-Dietheno-5a,12a-(methaniminomethano)-1H,5H,8H,12H-[1,2,4]triazolo[1,2-a][1,2,4]triazolo[1',2':1,2]pyridazino[4,5-d]pyridazine-18-acetic acid, 2,3,9,10-tetrahydro-.alpha.-(2-methylpropyl)-1,3,8,10,17,19-hexaoxo-2,9-diphenyl-, hexyl ester, stereoisomer
Quamoclin II peracetate[(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
Quamoclin I peracetate [(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
N-[4-[(2-chlorophenyl)[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl]methylene]-2,5-cyclohadien-1-ylidene]-N-ethyl-3-sulfobenzenemethanaminium trihydrogen {(trioxotungstato)(trioxomolybdato)phosphate]
Spiro[12,15:17,20-dietheno-6H,16H,22H-dibenzo[b,d][1,6,12,22]tetraox acycloheptacosin-16,4'-piperidine]-1,31-dimethanamine, 7,8,9,10,23,24,25,26-octahydro-N,N,N',N',1',13,19,32,35-nonamethyl-, (S)-
3-[N-(3',5'-Dimethylphenyl)-N-(phenylsulfonyl)amino]-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl 2-{5'-[(t-butyl)diphenylsilyloxy]-2,2-dimethyl-1-methylidenepentyl}-5-oxocyclopentanecarboxylate
N-[4-((2-chloro-4-sulfophenyl){3-methyl-4-[(3-sulfobenzyl)amino]phenyl}methylene)-2-methyl-2,5-cyclohexadien-1-ylidene](3-sulfophenyl)methanaminium trihydrogen [(trioxotungstato)(trioxomolybdato)phosphate]
Dibromo-{2,3,7,8-tetrahydro-2,2,3,3,7,7,8,8-octamethyl-N(1),N(9)-{ 2,2,2',2'-tetramethyl-1,1'-[(1R,2R)-(cyclohexane-1",2"-diyl)dinitrilo]-bis[propyl]}-1H-dipyrrine-1,9-diiminato(1-)}cobalt(III)
| Title | Journal or Book | Year |
|---|---|---|
| Norlanostane and Lanostane Glycosides from the Bulbs of Chionodoxa luciliae and Their Cytotoxic Activity. | Chemical and Pharmaceutical Bulletin | 2003 |